Buscar
Mostrando ítems 1-10 de 342
Does levodopa improve swallowing dysfunction in Parkinson’s disease patients?
(Blackwell Publishing, 2009)
Objective: To assess the influence of levodopa on swallowing dysfunction in Parkinson’s disease patients.
Methods: A systematic review of the literature and a meta-analysis were performed. All studies referring to levodopa ...
Consideraciones sobre las complicaciones motoras y neurotoxicidad de la levodopa en la enfermedad de Parkinson
(Sociedad de Neurología, Psiquiatría y Neurocirugía, 2005)
Levodopa en la enfermedad de Parkinson: ¿Qué hemos aprendido?
(Sociedad Médica de Santiago, 2006)
Levodopa effect upon functional balance of Parkinson's disease patients
(Elsevier B.V., 2004-10-01)
Objective. the aim of this study was to evaluate functional balance in PD patients taking levodopa during their 'on' and 'off' phases.Design. We evaluated 23 PD patients who were manifesting fluctuations of levodopa effect. ...
Determination of levodopa in human plasma by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS): application to a bioequivalence study
(Sociedade Brasileira de Química, 2014)
Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson
(Academia Brasileira de Neurologia - ABNEURO, 1995-12-01)
Dyskinesias are frequently observed in parkinsonian patients during levodopa treatment. The occurrence of these movement disorders usually makes the therapeutic management of the patients very difficult. The clinical ...
Swallowing improvement after levodopa treatment in idiopathic Parkinson's disease: Lack of evidence
(Parkinsonism & Related Disorders, 2013)
Swallowing impairment is the main cause of pulmonary infection and death in Parkinson's disease (PD). To date, there is no established effective treatment to restore swallowing function among these subjects. Levodopa is ...
Estudo de comunicação oral em pacientes com doença de Parkinson em fase OFF e ON, com o tratamento pela levodopa
(Universidade Federal de São Paulo (UNIFESP), 1997)